E-LIB Suche - Ergebnisse für: Eric Freire-Alvarez

1

Dyskinesia and Pain in Advanced Parkinson's Disease: Post H..:

Freire-Alvarez, Eric ; Vanni, Paola ; Kurča, Egon...
Neurology and Therapy. 13 (2024) 2 - p. 437-447 , 2024

2

Continuous subcutaneous foslevodopa/foscarbidopa infusion f..:

Fung, Victor S.C. ; Aldred, Jason ; Arroyo, Martha P....
Clinical Parkinsonism & Related Disorders. 10 (2024) - p. 100239 , 2024

Link: https://doi.org/10.1016/..

3

Concerns with the new biological research criteria for synu..:

Escamilla-Sevilla, Francisco ; Freire-Alvarez, Eric ; Martínez Castrillo, Juan C..
The Lancet Neurology. 23 (2024) 7 - p. 662 , 2024

Link: https://doi.org/10.1016/..

4

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkins..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V....
Neurology and Therapy. 12 (2023) 6 - p. 1937-1958 , 2023

Link: https://doi.org/10.1007/..

5

Correction: Continuous SubcutaneousFoslevodopa/Foscarbidopa..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V....
Neurology and Therapy. 12 (2023) 6 - p. 1959-1960 , 2023

Link: https://doi.org/10.1007/..

6

COVID-19-associated encephalitis successfully treated with ..:

Freire-Álvarez, Eric ; Guillén, Lucía ; Lambert, Karine...
Clinical Infection in Practice. 7-8 (2020) - p. 100053 , 2020

Link: https://doi.org/10.1016/..

7

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidop..:

Jason Aldred ; Eric Freire-Alvarez ; Alexander V. Amelin...
https://doi.org/10.1007/s40120-023-00554-w. , 2023

Link: https://doi.org/10.1007/..

8

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkins..:

Jason Aldred ; Eric Freire-Alvarez ; Alexander V. Amelin...
https://doi.org/10.1007/s40120-023-00533-1. , 2023

Link: https://doi.org/10.1007/..

9

COVID-19-associated encephalitis successfully treated with ..:

Eric Freire-Álvarez ; Lucía Guillén ; Karine Lambert...
http://www.sciencedirect.com/science/article/pii/S2590170220300406. , 2020

Link: https://doi.org/10.1016/..

10

Characterizing a Parkinson's Disease Population Inadequatel..:

Odin, Per ; Pahwa, Rajesh ; Farmer, Jill...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

11

Safety and Efficacy of 24-Hour/Day Subcutaneous Infusion of..:

Aldred, Jason ; Bergmans, Bruno ; Carroll, Camille...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

12

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkins..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V...
https://pure.au.dk/portal/da/publications/continuous-subcutaneous-foslevodopafoscarbidopa-in-parkinsons-disease(874ac0c1-bb79-4323-80c2-d1354a2fceff).html. , 2023

Link: https://pure.au.dk/porta..

13

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkins..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630297/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidop..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630263/. , 2023

Link: http://www.ncbi.nlm.nih...

15

MNCD: A New Tool for Classifying Parkinson's Disease in Dai..:

Santos García, Diego ; Álvarez Sauco, María ; Calopa, Matilde...
Diagnostics. 12 (2021) 1 - p. 55 , 2021

Link: https://doi.org/10.3390/..